Science Daily -
19 Sep 2018 19:30
A new study reports that effective management of neonatal abstinence syndrome (NAS) -- withdrawal symptoms occurring in infants exposed to opioids in utero -- requires a coordinated 'cascade of care' from prevention through long-term follow-up.
Share this Article